重組DNA技術市場規模、佔有率及成長分析（依產品、組件、應用、最終用途及地區分類）－2026-2033年產業預測

全球重組DNA技術市場規模預計到2024年將達到1,671.6億美元，到2025年將達到1797億美元，到2033年將達到3,204.9億美元，預測期（2026-2033年）的複合年成長率為7.5%。

全球重組DNA（rDNA）技術的進步對各個領域產生了變革性影響，使科學家能夠以前所未有的方式控制遺傳數據。這項技術已成功開發出不依賴人類捐贈者的重組藥物和療法，例如用於治療糖尿病的基因工程胰島素。生物技術和製藥行業正在積極探索rDNA技術的應用，以控制成本並拓展治療日益增多的慢性疾病的選擇。 rDNA技術的進步正在推動生物製藥的發展，尤其是在重組蛋白領域，這得益於CRISPR/Cas9、ZFN和TALEN等創新基因組編輯工具的支持。此外，基因改造作物的推廣應用也證明了rDNA在農業領域的有效性，並促進了對其在生質燃料和生物農藥領域應用潛力的探索。然而，圍繞基因治療的倫理問題仍然引發跨學科的辯論。

全球重組DNA技術市場促進因素

全球重組DNA技術市場的成長主要得益於關鍵產業參與者之間日益增多的策略聯盟，這些聯盟旨在增強其重組DNA技術實力。主要市場參與企業正積極與領先的生物製藥公司和研究機構合作，開發源自重組DNA技術的創新療法。這些合作有望加速該領域的進步，從而顯著促進市場成長。隨著這些策略聯盟的拓展，它們有望創造出更活躍的市場環境，促進新發現和應用，進一步推動整體市場的擴張。

限制全球重組DNA技術市場的因素

基因療法的高成本可能會限制許多潛在患者的接受治療，對全球重組DNA技術市場的擴張構成重大挑戰。此外，細胞激素釋放症候群（CRS）和神經毒性等不良反應引發了人們對安全性和有效性的擔憂，進一步阻礙了市場成長。同時，基因療法實踐中存在的倫理、法律和科學方面的限制也構成市場限制因素，導致相關人員和監管機構猶豫不決。這些因素綜合起來，對重組DNA技術在各個應用領域的進步和廣泛應用構成了重大障礙。

全球重組DNA技術市場趨勢

全球重組DNA技術市場呈現強勁成長勢頭，這主要得益於大眾對基因改造生物（GMO）接受度的不斷提高。在農業領域，基因改造生物顯著提高了作物產量和抗除草劑能力，尤其推動了這一趨勢。 DNA分子標記技術的整合促進了寶貴植物遺傳資源的鑑定和創新，進一步加速了市場擴張。此外，重組DNA技術在基因改造疫苗研發中的應用，為因應各種人類和植物疾病，也為醫學遺傳學和生物醫學領域創造了巨大的成長機會。該技術還可用於改造微生物以進行生物分解和無污染燃料生產，凸顯了其在多個領域的廣泛應用潛力。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球重組DNA技術市場規模（依產品及複合年成長率分類）（2026-2033年）

• 醫學領域
  • 治療劑
  • 人類蛋白質
  • 疫苗
• 非醫療領域
  • 生物技術作物
  • 特種化學品
  • 其他非醫療產品

全球重組DNA技術市場規模（按組成部分及複合年成長率分類）（2026-2033年）

• 表達系統
  • 哺乳動物系統
  • 細菌
  • 酵母菌
  • 桿狀病毒/昆蟲
  • 其他表達系統
• 克隆載體

全球重組DNA技術市場規模（依應用及複合年成長率分類）（2026-2033年）

• 食品和農業
• 健康/疾病領域
  • 人類
  • 動物
• 環境
• 其他用途

全球重組DNA技術市場規模（依最終用途及複合年成長率分類）（2026-2033年）

• 生物技術和製藥公司
• 學術和政府研究機構
• 其他用途

全球重組DNA技術市場規模及複合年成長率（2026-2033年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Thermo Fisher Scientific（US）
• Roche Holding AG（Switzerland）
• Merck KGaA（Germany）
• Agilent Technologies（US）
• Bio-Rad Laboratories（US）
• Illumina（US）
• Danaher Corporation（US）
• Sartorius AG（Germany）
• Lonza Group（Switzerland）
• Charles River Laboratories（US）
• GenScript Biotech Corporation（China）
• Twist Bioscience（US）
• Ginkgo Bioworks（US）
• Amyris（US）
• Synthetic Genomics（US）
• Intrexon（US）
• PerkinElmer（US）
• Eurofins Scientific（Luxembourg）

結論與建議

Global Recombinant DNA Technology Market size was valued at USD 167.16 Billion in 2024 and is poised to grow from USD 179.7 Billion in 2025 to USD 320.49 Billion by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).

Global insights into recombinant DNA (rDNA) technology reveal its transformative impact across various sectors, providing scientists unparalleled control over genetic data. This technology has successfully generated recombinant medications and therapeutics independent of human donors, exemplified by genetically modified insulin for diabetes treatment. Biotech and pharmaceutical industries are actively exploring rDNA applications to manage rising chronic illness costs and enhance therapeutic options. The evolution of rDNA techniques has spurred advancements in biopharmaceutical development, particularly in recombinant proteins supported by innovative genome-editing tools like CRISPR/Cas9, ZFN, and TALEN. Additionally, the expansion of genetically modified crops illustrates rDNA's agricultural effectiveness while prompting exploration of its potential in biofuels and biopesticides. However, ethical considerations surrounding gene therapy continue to spark debate across disciplines.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Recombinant DNA Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Recombinant DNA Technology Market Segments Analysis

Global Recombinant DNA Technology Market is segmented by Product, Component, Application, End Use and region. Based on Product, the market is segmented into Medical and Non-medical. Based on Component, the market is segmented into Expression System and Cloning Vector. Based on Application, the market is segmented into Food & Agriculture, Health & Disease, Environment and Other Applications. Based on End Use, the market is segmented into Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes and Other End Uses. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Recombinant DNA Technology Market

The growth of the Global Recombinant DNA Technology market is largely fueled by the rise in strategic partnerships among prominent industry players aimed at enhancing recombinant DNA technology. Major market participants are forging alliances with large biopharmaceutical firms and research institutions to develop innovative therapeutics derived from recombinant DNA techniques. These collaborative efforts are expected to accelerate advancements in the field, leading to significant market growth. As these strategic alliances proliferate, they will likely foster a more dynamic environment, pushing forward discoveries and applications that will further contribute to the overall expansion of the market.

Restraints in the Global Recombinant DNA Technology Market

The expansion of the Global Recombinant DNA Technology market faces significant challenges due to the high costs associated with gene therapy, which can limit accessibility for many potential patients. Additionally, adverse effects such as Cytokine Release Syndrome (CRS) and neurotoxicity further hinder market growth by raising concerns about safety and efficacy. Moreover, ethical, legal, and scientific limitations surrounding gene therapy practices contribute to market restraints, as these factors create hesitance among stakeholders and regulatory bodies. Collectively, these elements pose considerable obstacles to the advancement and adoption of recombinant DNA technologies in various applications.

Market Trends of the Global Recombinant DNA Technology Market

The Global Recombinant DNA Technology market is witnessing a robust trend driven by increasing public acceptance of genetically modified organisms (GMOs), particularly in agriculture, where genetically engineered crops enhance yield and herbicide resistance. The integration of DNA molecular marker technologies facilitates the identification and innovation of valuable plant germplasm, further boosting market expansion. Additionally, the application of recombinant DNA technology in the development of genetically modified vaccines addresses various human and plant diseases, creating substantial growth opportunities in medical genetics and biomedicine. This technology also enables the modification of microorganisms for bio-degradation and clean fuel production, underscoring its versatility across multiple sectors.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Recombinant DNA Technology Market Size by Product & CAGR (2026-2033)

• Market Overview
• Medical
  • Therapeutic Agent
  • Human Protein
  • Vaccine
• Non-medical
  • Biotech Crops
  • Specialty Chemicals
  • Other Non-medical Products

Global Recombinant DNA Technology Market Size by Component & CAGR (2026-2033)

• Market Overview
• Expression System
  • Mammalian
  • Bacteria
  • Yeast
  • Baculovirus / Insect
  • Other Expression Systems
• Cloning Vector

Global Recombinant DNA Technology Market Size by Application & CAGR (2026-2033)

• Market Overview
• Food & Agriculture
• Health & Disease
  • Human
  • Animal
• Environment
• Other Applications

Global Recombinant DNA Technology Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Biotechnology and Pharmaceutical Companies
• Academic & Government Research Institutes
• Other End Uses

Global Recombinant DNA Technology Market Size & CAGR (2026-2033)

• North America (Product, Component, Application, End Use)
  • US
  • Canada
• Europe (Product, Component, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Component, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Component, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Component, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ginkgo Bioworks (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amyris (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synthetic Genomics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intrexon (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations